Movahedi, Mohammad, Bishop, D. Timothy, Bisgaard, Marie-Luise, Dunlop, Malcolm G., Ho, Judy W. C., Hodgson, Shirley V., Lindblom, Annika, Lubinski, Jan, Morrison, Patrick J., Murday, Victoria, Ramesar, Raj S., Side, Lucy, Macrae, Finlay, Scott, Rodney J., Thomas, Huw J. W., Vasen, Hans F., Burn, John, Mathers, John C., Mecklin, Jukka-Pekka, Moeslein, Gabriela, Olschwang, Sylviane, Eccles, Diana, Evans, D. Gareth, Maher, Eamonn R., Bertario, Lucio. American Society of Clinical Oncology; 2015. Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: a prospective investigation in the CAPP2 study.

Burn, John, Gerdes, Anne-Marie, Bisgaard, Marie Louise, Dunlop, Malcolm G., Ho, Judy W. C., Hodgson, Shirley V., Lindblom, Annika, Lubinski, Jan, Morrison, Patrick J., Murday, Victoria, Ramesar, Raj, Side, Lucy, Macrae, Finlay, Scott, Rodney J., Thomas, Huw J. W., Vasen, Hans F., Barker, Gail, Crawford, Gillian, Elliott, Faye, Movahedi, Mohammad, Pylvanainen, Kirsi, Wijnen, Juul T., Fodde, Riccardo, Mecklin, Jukka-Pekka, Lynch, Henry T., Mathers, John C., Bishop, D. Timothy, Moeslein, Gabriela, Olschwang, Sylviane, Eccles, Diane, Evans, D. Gareth, Maher, Eamonn R., Bertario, Lucio. Lancet Publishing Group; 2011. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Carey, Mariko, Sanson-Fisher, Rob, Macrae, Finlay, Hill, David, D'Este, Catherine, Paul, Christine, Doran, Christopher. BioMed Central; 2012. Improving adherence to surveillance and screening recommendations for people with colorectal cancer and their first degree relatives: A randomized controlled trial.

Thompson, Bryony A., Spurdle, Amanda B., du Sart, Desiree, Fabre, Aurelie, Farrell, Michael P., Farrington, Susan M., Frayling, Ian M., Frebourg, Thierry, Goldgar, David E., Heinen, Christopher D., Holinski-Feder, Elke, Kohonen-Corish, Maija, Plazzer, John-Paul, Robinson, Kristina Lagerstedt, Leung, Suet Yi, Martins, Alexandra, Moller, Pat, Morak, Monika, Nystrom, Minna, Peltomaki, Paivi, Pineda, Marta, Qi, Ming, Ramesar, Rajkumar, Greenblatt, Marc S., Rasmussen, Lene Juel, Royer-Pokora, Brigitte, Scott, Rodney J., Sijmons, Rolf, Tavtigian, Sean V., Tops, Carli M., Weber, Thomas, Wijnen, Juul, Woods, Michael O., Macrae, Finlay, Akagi, Kiwamu, Genuardi, Maurizio, Al-Mulla, Fahd, Bapat, Bharati, Bernstein, Inge, Capellá, Gabriel, den Dunnen, John T.. Nature Publishing Group; 2014. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.

Burn, John, Sheth, Harsh, Gerdes, Anne-Marie, Ho, Judy W. C., Lindblom, Annika, Morrison, Patrick J., Rashbass, Jem, Ramesar, Raj, Seppälä, Toni, Thomas, Huw J. W., Pylvänäinen, Kirsi, Borthwick, Gillian M., Elliott, Faye, Mathers, John C., Bishop, DT, Boussioutas, A, Brewer, C, Cook, J, Eccles, D, Ellis, A, Hodgson, SV, Lubinski, J, Maher, ER, Reed, Lynn, Porteous, ME, Sampson, J, Scott, RJ, Side, L, Macrae, Finlay, Mecklin, Jukka-Pekka, Möslein, Gabriela, McRonald, Fiona E., Bertario, Lucio, Evans, D. Gareth. Lancet; 2020. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.

Burn, John, Bishop, Timothy, Bertario, Lucio, Jarvinen, Heikki J., Lindblom, Annika, Evans, D. Gareth, Lubinski, Jan, Morrison, Patrick J., Ho, Judy W. C., Vasen, Hans F. A., Side, Lucy, Thomas, Huw J. W., Mecklin, Jukka-Pekka, Scott, Rodney J., Dunlop, Malcolm, Barker, Gail, Elliott, Faye, Jass, Jeremy R., Fodde, Ricardo, Lynch, Henry T., Mathers, John C., Macrae, Finlay, Moslein, Gabriela, Olschwang, Sylviane, Bisgaard, Marie-Luise, Ramesar, Raj, Eccles, Diana, Maher, Eamonn R.. Massachusetts Medical Society; 2008. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.

Carey, Mariko, Sanson-Fisher, Robert, Macrae, Finlay, Cameron, Emilie, Hill, David, D'Este, Catherine, Simmons, Jody, Doran, Christopher. Wiley-Blackwell; 2016. Can a print-based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial.

Paul, Christine L., Cameron, Emilie, Doran, Christopher, Hill, David, Macrae, Finlay, Carey, Mariko L., Sanson-Fisher, Rob W.. Springer; 2016. Experiences of colorectal cancer patients in the 2-years post-diagnosis and patient factors predicting poor outcome.

Carey, Mariko, Sanson-Fisher, Robert, Macrae, Finlay, Cameron, Emilie, Hill, David, D'Este, Catherine, Doran, Christopher. BioMed Central; 2017. Improving adherence to colorectal cancer surveillance guidelines: results of a randomised controlled trial.

Reeves, Penny, Doran, Christopher, Carey, Mariko, Cameron, Emilie, Sanson-Fisher, Robert, Macrae, Finlay, Hill, David. Sage; 2019. Costs and cost-effectiveness of targeted, personalized risk information to increase appropriate screening by first-degree relatives of people with colorectal cancer.

Morrow, April, Hogden, Emily, Wolfenden, Luke, Mitchell, Gillian, Macrae, Finlay, Tucker, Kathy, Taylor, Natalie, Kan, Yoon-Jung, Canfell, Karen, Solomon, Michael J., Kench, James G., Gill, Anthony J., Shaw, Tim, Pachter, Nicholas, Parkinson, Bonny. BioMed Central; 2019. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol.

Ahadova, Aysel, Seppälä, Toni T., Laghi, Luigi, Dominguez-Valentin, Mev, Capella, Gabriel, Macrae, Finlay, Scott, Rodney, Hüneburg, Robert, Nattermann, Jacob, Hoffmeister, Michael, Brenner, Hermann, Bläker, Hendrik, Engel, Christoph, von Knebel Doeberitz, Magnus, Sampson, Julien R., Vasen, Hans, Mecklin, Jukka-Pekka, Møller, Pal, Kloor, Matthias, Gallon, Richard, Burn, John, Holinski-Feder, Elke, Steinke-Lange, Verena, Möslein, Gabriela, Nielsen, Maartje, ten Broeke, Sanne W.. John Wiley & Sons; 2021. The “unnatural” history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance.